Triamcinolone Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Apr 1, 2019.

• Overview
• Side Effects
• Dosage
• Professional
• Interactions
• Pregnancy
• More

Usual Adult Dose for Uveitis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical

Usual Adult Dose for Temporal Arteritis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical

Usual Adult Dose for Vitrectomy

1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Use: Visualization during vitrectomy

Usual Pediatric Dose for Uveitis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical

Usual Pediatric Dose for Temporal Arteritis

4 mg (100 microliters of 40 mg/mL suspension) with subsequent dosage as needed over the course of treatment

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Uses:
-Treatment of sympathetic ophthalmia
-Treatment of temporal arteritis
-Treatment of uveitis
-Treatment of ocular inflammatory conditions unresponsive to topical

Usual Pediatric Dose for Vitrectomy

1 to 4 mg (25 to 100 microliters of 40 mg/mL suspension) administered intravitreally

Comments:
-Strict aseptic technique is mandatory.
-The vial should be vigorously shaken for 10 seconds before use.
-Prior to withdrawal, the suspension should be inspected for clumping or granular appearance (agglomeration).
-After withdrawal, the suspension should be injected without delay.
-Careful technique should be employed to avoid the possibility of entering a blood vessel or introducing organisms that can cause infection.

Use: Visualization during vitrectomy

Renal Dose Adjustments

Renal insufficiency: Use with caution

Liver Dose Adjustments

Data not available

Precautions

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-The manufacturer product information should be consulted.

Storage requirements:
-Do not freeze.
-Protect from light.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer